Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NPCE - NeuroPace Inc

IEX Last Trade
11.13
4.340   38.994%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:21:01 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$6.79
4.34
63.92%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
10%
Profitability 0%
Dept financing 25%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.38%
1 Month
4.50%
3 Months
66.02%
6 Months
66.02%
1 Year
22.82%
2 Year
731.34%
Key data
Stock price
$11.13
P/E Ratio 
-7.73
DAY RANGE
$6.79 - $11.40
EPS 
-$1.09
52 WEEK RANGE
$6.06 - $18.15
52 WEEK CHANGE
$10.74
MARKET CAP 
231.240 M
YIELD 
N/A
SHARES OUTSTANDING 
29.197 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
BETA 
1.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$83,397
AVERAGE 30 VOLUME 
$75,385
Company detail
CEO: Michael Favet
Region: US
Website: www.neuropace.com
Employees: 170
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Recent news